Visalytics
Visalytics
approved EB-2 (NIW)

Research Scientist II

Medicinal Chemistry · India · 2023-06-07

Processing Time
2 days
Decision Date
2023-06-07
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to research and develop new chemical synthesis methods for novel therapeutic agents and implement medicinal chemical strategies for developing novel antimicrobial therapeutic agent-discovery programs. This work specifically targets pressing issues such as antimicrobial resistance, antibiotic discovery, and the treatment of Alzheimer’s disease.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses critical national issues including antimicrobial resistance and Alzheimer’s disease treatment.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 26 publications, 516 citations, and 102 peer reviews demonstrates his leading expertise and influence.

3 Waiver Benefit Met

The petitioner's unique expertise in drug-like small molecule discovery makes his continued work essential to the U.S. research community.

Why This Petition Was Approved

The petition was approved based on the petitioner's PhD in medicinal chemistry and an extraordinary record of 26 peer-reviewed scientific articles which gathered 516 citations from researchers in 41 countries. Additionally, the petitioner completed 102 peer reviews and received funding from major agencies like the NIGMS and NIDA, satisfying the Dhanasar prongs for NIW and the high standards for EB1A.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Original Contributions
Judging Experience
Government Alignment

Similar Cases

Scientist

Pharmaceuticals · India

WeGreened EB-2 (NIW) approved
Wisconsin 94 days 2025-01-29
The petitioner proposes to investigate the design, synthesis, optimization, and characterization of small molecule compounds. This work focuses on developing therapeutic agents to address drug-resistant infections and improve medication safety and efficacy.
View Case

Others

Pharmaceuticals · Taiwan

WeGreened EB-2 (NIW) approved
Georgia 303 days 2025-03-25
The petitioner proposes to utilize organic synthesis and structure-activity relationship (SAR) studies to develop new pharmaceutical compounds. The work focuses on creating novel chemical motifs and predictive modeling to improve therapies for antimicrobial-resistant infections and mitigate critical drug shortages.
View Case

Scientist

Pharmaceuticals · Bangladesh

WeGreened EB-2 (NIW) approved
Massachusetts 69 days 2022-04-19
The petitioner proposes to continue analyzing synthetic routes to isolate, synthesize, design, and ensure the safety of novel drug molecules. This work is part of innovative drug discovery projects aimed at treating cancer, heart disease, and infectious diseases to improve global and U.S. healthcare outcomes.
View Case

Research Scientist

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Utah 52 days 2025-03-07
The petitioner proposes to design and develop novel antimicrobial compounds for in vitro and in vivo applications to combat resistant pathogens and bridge the gap between basic discovery and clinical translation.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-06-07.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 2 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist